Back to search

Ireland· IE-PA-PA1286/058/001

Esmeron 10 mg/ml solution for injection/infusion

A rocuronium bromide product containing rocuronium bromide, registered in Ireland by Merck Sharp & Dohme Ireland (Human Health) Limited. The same ATC class is registered in 13 of our 19 countries.

ATC M03AC09

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedEsmeron 10 mg/ml solution for injecti…ATCM03AC09REGISTER NO.IE-PA-PA1286/058/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Rocuronium bromide is registered in 13 of 19 countries.

Countries holding a registration under ATC M03AC09 (rocuronium bromide), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Rocuronium bromide · ATC M03AC09

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Rocuronium bromide
Manufacturer
Merck Sharp & Dohme Ireland (Human Health) Limited
Country
Ireland (IE)
ATC code
M03AC09
ATC class
Rocuronium bromide
Defined daily dose
42 mg, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1286/058/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

109 interactions on record for rocuronium bromide.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rocuronium bromide · interactions on record

109 records

  • 12 severe
  • 59 moderate
  • 4 minor
  • 34 info

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • ParomomycinA07AA06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rocuronium bromide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rocuronium bromide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Rocuronium Kalceks, Rocuroniumbromid Accord
  • Belgium · Esmeron, Rocuronium B. Braun
  • Bulgaria · Рокурониев Ромфарм, Рокурониум Б. Браун
  • Cyprus · Esmeron, Rocudem
  • Czechia · Esmeron, Rocuronium B. Braun
  • Germany · Rocuronium Aguettant, Rocuronium Inresa
  • Denmark · Rocuronium Bromide Accord, Rocuronium Bromide Aguettant
  • Estonia · Rocuronium Bromide Fresenius Kabi, Rocuronium Bromide Kalceks
  • Spain · Rocuronio Aguettant, Rocuronio B. Braun
  • Finland · Rocuronium B. Braun, Rocuronium Bromide Accord
  • France · Rocuronium, Rocuronium Aguettant
  • United Kingdom (Northern Ireland) · Esmeron, Rocuronium B. Braun Melsungen
  • Greece · Esmeron, Rocudem
  • Croatia · Rokuronijev Bromid B. Braun, Rokuronijev Bromid Fresenius Kabi
  • Hungary · Rocuronium Bromide Hameln, Rocuronium Bromide Noridem
  • Iceland · Rocuronium Aguettant
  • Italy · Esmeron, Rocuronio Accord
  • Lithuania · Rocuronium Bromide Kalceks, Roqurum
  • Luxembourg · Esmeron, Rocuronium Bromide Aguettant
  • Latvia · Rocuronium Bromide Kalceks
  • Malta · Rocuronium Bromide As Kalceks, Rocuronium Bromide Ibigen
  • Netherlands · Esmeron, Rocuroniumbromide Accord
  • Norway · Rocuronium Bromide Accord, Rocuronium Bromide Aguettant
  • Poland · Rocuronium, Rocuronium Bromide Hameln
  • Portugal · Brometo De Rocurónio Accord, Brometo De Rocurónio Aguettant
  • Romania · Esmeron, Rocuronium Aguettant
  • Sweden · Rocuronium Accord, Rocuronium B. Braun
  • Slovenia · Rokuronijev Bromid B. Braun, Rokuronijev Bromid Hameln
  • Slovakia · Rocuronium B. Braun, Rocuronium Bromide Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/54d5a5ba-6845-44eb-b107-bbee738e7647
GET /v1/drugs/54d5a5ba-6845-44eb-b107-bbee738e7647?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection/infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "M03AC",
    "M03AC09"
  ],
  "strength": null,
  "pa_number": "PA1286/058/001",
  "substances": [
    "Rocuronium bromide"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "07/08/1996",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about rocuronium bromide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.